Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: Comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 10, 1996, Pages 944-948

  Sato, Akira ^a   Kato, Yuji ^a   Nakata, Keisuke ^a   Nakao, Kazuhiko ^a   Daikoku, Manabu ^a   Ishii, Nobuko ^a   Matsumoto, Takehiro ^a   Iseki, Keiko ^a   Mazume, Hiroyuki ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

alanine aminotransferase; hepatitis C virus; hepatocellular carcinoma; liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS ANTIGEN;

ARTICLE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 10144225636     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00278.x     Document Type: Article

References (27)

1. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-38.
2. Bosch FX, Munoz N. Hepatocellular carcinoma in the world: Epidemiologic question. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Epidemiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf, 1991; 35-54.
3. Beasley RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-56.
4. Zaman SN, Meria WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients. Lancet 1985; i: 1357-60.
5. Choo QL, Kuo G, Wiener AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
6. Kuo G, Choo QL, Alter JH et al. An assay for circulating antibodies to a major etiologic agent of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
7. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki Y. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-33.
8. Kato Y, Nakata K, Omagari K et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan: Analysis of infectious hepatitis viruses. Cancer 1994; 74: 2234-8.
9. Hamasaki K, Nakata K, Tsutsumi T et al. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki prefecture, Japan. J. Med. Virol. 1993; 40: 146-9.
10. Tanaka K, Hirohata T, Koga S et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res. 1991; 51: 2842-7.
11. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology 1992; 15: 948-63.
12. Nonomura A, Ohta G, Hayashi M et al. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma. Am. J. Gastroenterol. 1987; 82: 512-18.
13. Su TS, Lin LH, Lui WY et al. Expression of c-myc gene in human hepatoma. Biochem. Biophys. Res. Commun. 1985; 132: 264-8.
14. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res. 1993; 53: 2884-7.
15. Kaplan EL, Meier P. Non parametric estimation for incomplete observation. J. Am. Stat. Assoc. 1958; 53: 457-81.
16. Colombo M, De Franchis R, Del Ninno E et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med. 1991; 325: 675-80.
17. Ikeda K, Saitoh S, Koida I et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatohgy 1993; 18: 47-53.
18. Oka H, Kurioka N, Kum K et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-7.
19. Benvegnú L, Fattovich G, Noventa F et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer 1994; 74: 2442-8.
20. Aihara T, Noguchi S, Sasaki Y, Nakano H, Imaoka S. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. Gastroenterology 1994; 107: 1805-11.
21. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980; 286: 533-5.
22. Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hotschnerder PH, Koshy R. The PreS2/S region of integrated hepatitis B virus DNA encodes a transcriptional trans-activation. Nature 1990; 334: 457-61.
23. Takada S, Koike K. Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissue. Proc. Natl Acad. Sci. USA 1990; 87: 5628-32.
24. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-20.
25. van Doom LJ. Molecular biology of the hepatitis C virus. J. Med. Virol. 1994; 43: 345-56.
26. Taro K, Ohkawa S, Shimizu A et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from antibody to hepatitis C virus-positive cirrhotic patients. Cancer 1994; 73: 1149-54.
27. Kew MC. Cancer of the liver. Curr. Opin. Gastroenterol. 1995; 11: 202-6.